Antiarrhythmic Mechanisms of SK Channel Inhibition in the Rat Atrium

Introduction: SK channels have functional importance in the cardiac atrium of many species, including humans. Pharmacological blockage of SK channels has been reported to be antiarrhythmic in animal models of atrial fibrillation; however, the exact antiarrhythmic mechanism of SK channel inhibition remains unclear. Objectives: We speculated that together with a direct inhibition of repolarizing SK current, the previously observed depolarization of the atrial resting membrane potential (RMP) after SK channel inhibition reduces sodium channel availability, thereby prolonging the effective refractory period and slowing the conduction velocity (CV). We therefore aimed at elucidating these properties of SK channel inhibition and the underlying antiarrhythmic mechanisms using microelectrode action potential (AP) recordings and CV measurements in isolated rat atrium. Automated patch clamping and two-electrode voltage clamp were used to access INa and IK,ACh, respectively. Results: The SK channel inhibitor N-(pyridin-2-yl)-4-(pyridin-2-yl)thiazol-2-amine (ICA) exhibited antiarrhythmic effects. ICA prevented electrically induced runs of atrial fibrillation in the isolated right atrium and induced atrial postrepolarization refractoriness and depolarized RMP. Moreover, ICA (1–10 &mgr;M) was found to slow CV; however, because of a marked prolongation of effective refractory period, the calculated wavelength was increased. Furthermore, at increased pacing frequencies, SK channel inhibition by ICA (10–30 &mgr;M) demonstrated prominent depression of other sodium channel–dependent parameters. ICA did not inhibit IK,ACh, but at concentrations above 10 &mgr;M, ICA use dependently inhibited INa. Conclusions: SK channel inhibition modulates multiple parameters of AP. It prolongs the AP duration and shifts the RMP towards more depolarized potentials through direct ISK block. This indirectly leads to sodium channel inhibition through accumulation of state dependently inactivated channels, which ultimately slows conduction and decreases excitability. However, a contribution from a direct sodium channel inhibition cannot be ruled. We here propose that the primary antiarrhythmic mechanism of SK channel inhibition is through direct potassium channel block and through indirect sodium channel inhibition.

[1]  Xiaozhi Cao,et al.  Association between SNP rs13376333 and rs1131820 in the KCNN3 gene and atrial fibrillation in the Chinese Han population , 2014, Clinical chemistry and laboratory medicine.

[2]  Lei Yuan,et al.  Small-conductance calcium-activated potassium (SK) channels contribute to action potential repolarization in human atria. , 2014, Cardiovascular research.

[3]  J. M. Di Diego,et al.  Ranolazine Effectively Suppresses Atrial Fibrillation in the Setting of Heart Failure , 2014, Circulation. Heart failure.

[4]  S. Mahida Expanding role of SK channels in cardiac electrophysiology. , 2014, Heart rhythm.

[5]  D. Terentyev,et al.  Sarcoplasmic reticulum Ca²⁺ release is both necessary and sufficient for SK channel activation in ventricular myocytes. , 2014, American journal of physiology. Heart and circulatory physiology.

[6]  S. Nattel,et al.  Role of Small-Conductance Calcium-Activated Potassium Channels in Atrial Electrophysiology and Fibrillation in the Dog , 2014, Circulation.

[7]  J. Weiss,et al.  Apamin induces early afterdepolarizations and torsades de pointes ventricular arrhythmia from failing rabbit ventricles exhibiting secondary rises in intracellular calcium. , 2013, Heart rhythm.

[8]  A. Ma,et al.  Bisoprolol reversed small conductance calcium-activated potassium channel (SK) remodeling in a volume-overload rat model , 2013, Molecular and Cellular Biochemistry.

[9]  B. Nguyen,et al.  Heterogeneous Upregulation of Apamin‐Sensitive Potassium Currents in Failing Human Ventricles , 2013, Journal of the American Heart Association.

[10]  A. Dolga,et al.  KCa2 and KCa3 Channels in Learning and Memory Processes, and Neurodegeneration , 2012, Front. Pharmacol..

[11]  N. Holstein-Rathlou,et al.  Angiotensin II does not acutely regulate conduction velocity in rat atrial tissue , 2011, Scandinavian journal of clinical and laboratory investigation.

[12]  J. Svendsen,et al.  Screening of KCNN3 in patients with early-onset lone atrial fibrillation. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[13]  U. Sørensen,et al.  Effects on Atrial Fibrillation in Aged Hypertensive Rats by Ca2+-Activated K+ Channel Inhibition , 2011, Hypertension.

[14]  U. Sørensen,et al.  The Duration of Pacing-induced Atrial Fibrillation Is Reduced in Vivo by Inhibition of Small Conductance Ca2+-activated K+ Channels , 2011, Journal of cardiovascular pharmacology.

[15]  J. Weiss,et al.  Small-Conductance Calcium-Activated Potassium Channel and Recurrent Ventricular Fibrillation in Failing Rabbit Ventricles , 2011, Circulation research.

[16]  N. Chiamvimonvat,et al.  Cardiac Small Conductance Ca2+-Activated K+ Channel Subunits Form Heteromultimers via the Coiled-Coil Domains in the C Termini of the Channels , 2010, Circulation research.

[17]  B. Fakler,et al.  Ca2+-activated K+ channels: from protein complexes to function. , 2010, Physiological reviews.

[18]  U. Sørensen,et al.  Inhibition of Small-Conductance Ca2+-Activated K+ Channels Terminates and Protects Against Atrial Fibrillation , 2010, Circulation. Arrhythmia and electrophysiology.

[19]  Thomas Meitinger,et al.  Common Variants in KCNN3 are Associated with Lone Atrial Fibrillation , 2010, Nature Genetics.

[20]  M. Poss,et al.  Initial SAR studies on apamin-displacing 2-aminothiazole blockers of calcium-activated small conductance potassium channels. , 2008, Bioorganic & medicinal chemistry letters.

[21]  P. Pedarzani,et al.  Molecular and cellular basis of small- and intermediate-conductance, calcium-activated potassium channel function in the brain , 2008, Cellular and Molecular Life Sciences.

[22]  H. Matsubara,et al.  Generation of reentrant arrhythmias by dominant-negative inhibition of connexin43 in rat cultured myocyte monolayers. , 2008, Cardiovascular research.

[23]  N. Holstein-Rathlou,et al.  The Antiarrhythmic Peptide Analog ZP123 Prevents Atrial Conduction Slowing During Metabolic Stress , 2005, Journal of cardiovascular electrophysiology.

[24]  José Jalife,et al.  Mechanisms of Atrial Fibrillation Termination by Pure Sodium Channel Blockade in an Ionically-Realistic Mathematical Model , 2005, Circulation research.

[25]  M. Stocker Ca2+-activated K+ channels: molecular determinants and function of the SK family , 2004, Nature Reviews Neuroscience.

[26]  Kuljit Singh,et al.  Small and intermediate conductance Ca2+-activated K+ channels confer distinctive patterns of distribution in human tissues and differential cellular localisation in the colon and corpus cavernosum , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

[27]  G. Wang,et al.  State-dependent Block of Wild-type and Inactivation-deficient Na+ Channels by Flecainide , 2003, The Journal of general physiology.

[28]  K. Harlow,et al.  ZP123 Increases Gap Junctional Conductance and Prevents Reentrant Ventricular Tachycardia During Myocardial Ischemia in Open Chest Dogs , 2003, Journal of cardiovascular electrophysiology.

[29]  Y. Park,et al.  Ion selectivity and gating of small conductance Ca(2+)‐activated K+ channels in cultured rat adrenal chromaffin cells. , 1994, The Journal of physiology.

[30]  Lammers Wj,et al.  Pathophysiology of atrial fibrillation: current aspects. , 1993, Herz.

[31]  N. Benowitz,et al.  Poisoning Due to Class IA Antiarrhythmic Drugs , 1990 .

[32]  A. K. Ritchie,et al.  Tetraethylammonium ion sensitivity of a 35-pS Ca2+-activated K+ channel in GH3 cells that is activated by thyrotropin-releasing hormone , 1990, Pflügers Archiv.

[33]  Stanley Nattel,et al.  Novel Approaches for Pharmacological Management of Atrial Fibrillation , 2012, Drugs.

[34]  S. Olesen,et al.  Apamin interacts with all subtypes of cloned small-conductance Ca2+-activated K+ channels , 2000, Pflügers Archiv.

[35]  Y. Kihara,et al.  Mechanisms of negative inotropic effects of class Ic antiarrhythmic agents: comparative study of the effects of flecainide and pilsicainide on intracellular calcium handling in dog ventricular myocardium. , 1996, Journal of cardiovascular pharmacology.

[36]  N. Benowitz,et al.  Poisoning due to class IA antiarrhythmic drugs. Quinidine, procainamide and disopyramide. , 1990, Drug safety.